Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Avandia to be to Studied for Prevention of Type 2 Diabetes
SmithKline Beecham announced in a November 8, 2000 press release that its type 2 drug Avandia (rosiglitazone) will be the only diabetes drug studied in a first-of-its kind, multi-national, 4,000-person study to determine the impact of intensive drug therapy on preventing type 2 diabetes.
Led by Doctors Hertzel Gerstein and Salim Yusuf of McMaster University in Canada, this study, known as the DREAM trial (Diabetes Reduction Approaches with Ramipril and Rosiglitazone Medications), follows last year's HOPE study (Heart Outcomes Prevention Evaluation), which concluded that using the ACE inhibitor Ramipril improved cardio-vascular outcomes.
DREAM is the first study to extensively evaluate the ability of intensive therapy with Avandia and/or Ramipril to prevent diabetes.
Avandia targets insulin resistance and treats this underlying cause of type 2 diabetes.
"Therefore, testing the hypothesis that Avandia should prevent or delay the progression of type 2 diabetes is a logical next step," says David M. Stout, president-North America, SmithKline Beecham Phar-maceuticals.
"Clearly the best way to prevent the serious health consequence of diabetes is to prevent it from occurring in the first place," says Jeff Probstfield, MD, professor of medicine and epidemiology at University of Washington Health Sciences Center and U.S. DREAM investigator.
The DREAM study will be funded by SmithKline Beecham Pharmaceuticals, King Pharmaceuticals and Aventis Pharma Canada.
Categories: Diabetes, Diabetes, Insulin, Medications Research, Type 2 Issues, Type 2 Medications
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...